WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+13.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$1.65B
(+18%)
Cap. Flow
+$863M
Cap. Flow
% of AUM
7.98%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
675
New
211
Increased
170
Reduced
126
Closed
150
Top Buys
| 1 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 2 |
TE Connectivity
TEL
|
$84.6M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$78.6M |
| 4 |
Honeywell
HON
|
$72.8M |
| 5 |
Palo Alto Networks
PANW
|
$71.1M |
Top Sells
| 1 |
AbbVie
ABBV
|
$116M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$113M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$88.1M |
| 4 |
Permian Resources
PR
|
$75M |
| 5 |
SPLK
Splunk Inc
SPLK
|
$70.1M |
Sector Composition
| 1 | Healthcare | 38.65% |
| 2 | Technology | 22.91% |
| 3 | Industrials | 9.85% |
| 4 | Energy | 8.37% |
| 5 | Consumer Discretionary | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Regenxbio
RGNX
$490M
| $3.08M | 0.03% |
+146,334
| New | +$3.08M |
|
402
BellRing Brands
BRBR
$4.97B
| $2.94M | 0.03% |
+49,871
| New | +$2.94M |
|
403
American Airlines Group
AAL
$8.63B
| $2.91M | 0.03% |
+189,703
| New | +$2.91M |
|
404
RAPT Therapeutics
RAPT
$214M
| $2.89M | 0.03% |
40,202
+15,052
| +60% | +$1.08M |
|
405
Flex
FLEX
$20.8B
| $2.85M | 0.03% |
99,479
-785,864
| -89% | -$22.5M |
|
406
Semtech
SMTC
$5.26B
| $2.81M | 0.03% |
102,052
+8,470
| +9% | +$233K |
|
407
Voyager Therapeutics
VYGR
$235M
| $2.79M | 0.03% |
+300,000
| New | +$2.79M |
|
408
Vor Biopharma
VOR
$248M
| $2.63M | 0.02% |
1,111,123
| – | – |
|
409
Aquestive Therapeutics
AQST
$656M
| $2.56M | 0.02% |
+600,592
| New | +$2.56M |
|
410
Sweetgreen
SG
$1.06B
| $2.52M | 0.02% |
+99,848
| New | +$2.52M |
|
411
Aurinia Pharmaceuticals
AUPH
$1.63B
| $2.51M | 0.02% |
500,555
-144,639
| -22% | -$725K |
|
412
Zurn Elkay Water Solutions
ZWS
$7.71B
| $2.48M | 0.02% |
+74,056
| New | +$2.48M |
|
413
Perrigo
PRGO
$3.12B
| $2.44M | 0.02% |
75,819
| – | – |
|
414
Progress Software
PRGS
$1.88B
| $2.43M | 0.02% |
45,575
-23,333
| -34% | -$1.24M |
|
415
BBB Foods
TBBB
$3B
| $2.43M | 0.02% |
+102,077
| New | +$2.43M |
|
416
Replimune Group
REPL
$494M
| $2.4M | 0.02% |
293,622
| – | – |
|
417
Relay Therapeutics
RLAY
$710M
| $2.27M | 0.02% |
273,008
+23,008
| +9% | +$191K |
|
418
EverCommerce
EVCM
$2.06B
| $2.24M | 0.02% |
237,885
-31,087
| -12% | -$293K |
|
419
Altimmune
ALT
$334M
| $2.18M | 0.02% |
+214,245
| New | +$2.18M |
|
420
iShares MSCI Brazil ETF
EWZ
$5.47B
| $2.06M | 0.02% |
+63,690
| New | +$2.06M |
|
|
SAGE
421
DELISTED
Sage Therapeutics
SAGE
| $1.96M | 0.02% |
+104,831
| New | +$1.96M |
|
422
Trade Desk
TTD
$25.5B
| $1.94M | 0.02% |
22,232
-3,513
| -14% | -$307K |
|
423
Alto Neuroscience
ANRO
$99.4M
| $1.92M | 0.02% |
+125,000
| New | +$1.92M |
|
424
Erasca
ERAS
$457M
| $1.84M | 0.02% |
890,793
-28,326
| -3% | -$58.4K |
|
|
FNA
425
DELISTED
Paragon 28, Inc.
FNA
| $1.79M | 0.02% |
144,676
-355,796
| -71% | -$4.39M |
|